179 related articles for article (PubMed ID: 27986508)
1. Screening Breast MRI Outcomes in Routine Clinical Practice: Comparison to BI-RADS Benchmarks.
Strigel RM; Rollenhagen J; Burnside ES; Elezaby M; Fowler AM; Kelcz F; Salkowski L; DeMartini WB
Acad Radiol; 2017 Apr; 24(4):411-417. PubMed ID: 27986508
[TBL] [Abstract][Full Text] [Related]
2. Performance Benchmarks for Screening Breast MR Imaging in Community Practice.
Lee JM; Ichikawa L; Valencia E; Miglioretti DL; Wernli K; Buist DSM; Kerlikowske K; Henderson LM; Sprague BL; Onega T; Rauscher GH; Lehman CD
Radiology; 2017 Oct; 285(1):44-52. PubMed ID: 28582633
[TBL] [Abstract][Full Text] [Related]
3. Proposed biopsy performance benchmarks for MRI based on an audit of a large academic center.
Sedora Román NI; Mehta TS; Sharpe RE; Slanetz PJ; Venkataraman S; Fein-Zachary V; Dialani V
Breast J; 2018 May; 24(3):319-324. PubMed ID: 28833841
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Predictive Value of BI-RADS 3, 4, and 5 Lesions Detected on Breast MRI: Correlation with Study Indication.
Chikarmane SA; Tai R; Meyer JE; Giess CS
Acad Radiol; 2017 Apr; 24(4):435-441. PubMed ID: 27955878
[TBL] [Abstract][Full Text] [Related]
5. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ.
Friedlander LC; Roth SO; Gavenonis SC
Radiology; 2011 Nov; 261(2):421-7. PubMed ID: 21900618
[TBL] [Abstract][Full Text] [Related]
6. Auditing a breast MRI practice: performance measures for screening and diagnostic breast MRI.
Niell BL; Gavenonis SC; Motazedi T; Chubiz JC; Halpern EP; Rafferty EA; Lee JM
J Am Coll Radiol; 2014 Sep; 11(9):883-9. PubMed ID: 24787571
[TBL] [Abstract][Full Text] [Related]
7. Performance of Screening Breast MRI across Women with Different Elevated Breast Cancer Risk Indications.
Sippo DA; Burk KS; Mercaldo SF; Rutledge GM; Edmonds C; Guan Z; Hughes KS; Lehman CD
Radiology; 2019 Jul; 292(1):51-59. PubMed ID: 31063080
[TBL] [Abstract][Full Text] [Related]
8. Breast MRI BI-RADS assessments and abnormal interpretation rates by clinical indication in US community practices.
Lee CI; Ichikawa L; Rochelle MC; Kerlikowske K; Miglioretti DL; Sprague BL; DeMartini WB; Wernli KJ; Joe BN; Yankaskas BC; Lehman CD
Acad Radiol; 2014 Nov; 21(11):1370-6. PubMed ID: 25126973
[TBL] [Abstract][Full Text] [Related]
9. National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium.
Lehman CD; Arao RF; Sprague BL; Lee JM; Buist DS; Kerlikowske K; Henderson LM; Onega T; Tosteson AN; Rauscher GH; Miglioretti DL
Radiology; 2017 Apr; 283(1):49-58. PubMed ID: 27918707
[TBL] [Abstract][Full Text] [Related]
10. An Abbreviated Protocol for High-risk Screening Breast Magnetic Resonance Imaging: Impact on Performance Metrics and BI-RADS Assessment.
Panigrahi B; Mullen L; Falomo E; Panigrahi B; Harvey S
Acad Radiol; 2017 Sep; 24(9):1132-1138. PubMed ID: 28506511
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome assessment in mammography: an audit of 7,506 screening and diagnostic mammography examinations.
Tunçbilek I; Ozdemir A; Gültekin S; Oğur T; Erman R; Yüce C
Diagn Interv Radiol; 2007 Dec; 13(4):183-7. PubMed ID: 18092288
[TBL] [Abstract][Full Text] [Related]
12. Screening Breast MRI in Patients Previously Treated for Breast Cancer: Diagnostic Yield for Cancer and Abnormal Interpretation Rate.
Giess CS; Poole PS; Chikarmane SA; Sippo DA; Birdwell RL
Acad Radiol; 2015 Nov; 22(11):1331-7. PubMed ID: 26142951
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ.
Nakhlis F; Harrison BT; Giess CS; Lester SC; Hughes KS; Coopey SB; King TA
Ann Surg Oncol; 2019 Jan; 26(1):55-61. PubMed ID: 30362065
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of abbreviated breast MRI for screening of women with previously treated breast cancer.
Kwon MR; Ko EY; Han BK; Ko ES; Choi JS; Park KW
Medicine (Baltimore); 2020 Apr; 99(16):e19676. PubMed ID: 32311941
[TBL] [Abstract][Full Text] [Related]
15. BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors.
Yao MM; Joe BN; Sickles EA; Lee CS
Acad Radiol; 2019 Aug; 26(8):1048-1052. PubMed ID: 30195413
[TBL] [Abstract][Full Text] [Related]
16. Breast Cancer Screening with Abbreviated Breast MRI: 3-year Outcome Analysis.
Kwon MR; Choi JS; Won H; Ko EY; Ko ES; Park KW; Han BK
Radiology; 2021 Apr; 299(1):73-83. PubMed ID: 33620293
[TBL] [Abstract][Full Text] [Related]
17. Utility of BI-RADS Assessment Category 4 Subdivisions for Screening Breast MRI.
Strigel RM; Burnside ES; Elezaby M; Fowler AM; Kelcz F; Salkowski LR; DeMartini WB
AJR Am J Roentgenol; 2017 Jun; 208(6):1392-1399. PubMed ID: 28792802
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
Comstock CE; Gatsonis C; Newstead GM; Snyder BS; Gareen IF; Bergin JT; Rahbar H; Sung JS; Jacobs C; Harvey JA; Nicholson MH; Ward RC; Holt J; Prather A; Miller KD; Schnall MD; Kuhl CK
JAMA; 2020 Feb; 323(8):746-756. PubMed ID: 32096852
[TBL] [Abstract][Full Text] [Related]
19. Performance of Screening Breast MRI After Negative Full-Field Digital Mammography Versus After Negative Digital Breast Tomosynthesis in Women at Higher Than Average Risk for Breast Cancer.
Roark AA; Dang PA; Niell BL; Halpern EF; Lehman CD
AJR Am J Roentgenol; 2019 Feb; 212(2):271-279. PubMed ID: 30540208
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
